Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface

被引:56
作者
Bentley, J
Itchayanan, D
Barnes, K
McIntosh, E
Tang, XW
Downes, CP
Holman, GD
Whetton, AD
Owen-Lynch, PJ
Baldwin, SA
机构
[1] Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Dundee, Dept Biochem, Dundee DD1 5EH, Scotland
[3] Univ Bath, Sch Biol & Biochem, Bath BA2 7AY, Avon, England
[4] Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Leukaemia Res Fund Unit, Manchester M60 1QD, Lancs, England
关键词
D O I
10.1074/jbc.M305689200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Maintenance of glucose uptake is a key component in the response of hematopoietic cells to survival factors. To investigate the mechanism of this response we employed the interleukin-3 (IL-3)-dependent murine mast cell line IC2.9. In these cells, hexose uptake decreased markedly upon withdrawal of IL-3, whereas its readdition led to rapid (t(1/2) similar to 10 min) stimulation of transport, associated with an similar to4-fold increase in V-max but no change in Km. Immunocytochemistry and photoaffinity labeling revealed that IL-3 caused translocation of intracellular GLUT1 transporters to the cell surface, whereas a second transporter isoform, GLUT3, remained predominantly intracellular. The inhibitory effects of latrunculin B and jasplakinolide, and of nocodazole and colchicine, respectively, revealed a requirement for both the actin and microtubule cytoskeletons in GLUT1 translocation and transport stimulation. Both IL-3 stimulation of transport and GLUT1 translocation were also prevented by the phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002. The time courses for activation of phosphatidylinositol 3-kinase and its downstream target, protein kinase B, by IL-3 were consistent with a role in IL-3-induced transporter translocation and enhanced glucose uptake. We conclude that one component of the survival mechanisms elicited by IL-3 involves the subcellular redistribution of glucose transporters, thus ensuring the supply of a key metabolic substrate.
引用
收藏
页码:39337 / 39348
页数:12
相关论文
共 43 条
[1]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[2]   Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway [J].
Arai, A ;
Kanda, E ;
Miura, O .
ONCOGENE, 2002, 21 (17) :2641-2651
[3]   Glucose transport regulation by p210 Bcr-Abl in a chronic myeloid leukaemia model [J].
Bentley, J ;
Walker, I ;
McIntosh, E ;
Whetton, AD ;
Owen-Lynch, PJ ;
Baldwin, SA .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (01) :212-215
[4]  
Berridge MV, 1996, J IMMUNOL, V156, P4092
[5]   INTERLEUKIN-3 FACILITATES GLUCOSE-TRANSPORT IN A MYELOID CELL-LINE BY REGULATING THE AFFINITY OF THE GLUCOSE-TRANSPORTER FOR GLUCOSE - INVOLVEMENT OF PROTEIN-PHOSPHORYLATION IN TRANSPORTER ACTIVATION [J].
BERRIDGE, MV ;
TAN, AS .
BIOCHEMICAL JOURNAL, 1995, 305 :843-851
[6]   Regulated transport of the glucose transporter glut4 [J].
Bryant, NJ ;
Govers, R ;
James, DE .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (04) :267-277
[7]  
CHAPMAN RS, 1996, HEMATOPOIETIC CELL G, P151
[8]   Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling [J].
Craddock, BL ;
Orchiston, EA ;
Hinton, HJ ;
Welham, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (15) :10633-10640
[9]   Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family [J].
de Groot, RP ;
Coffer, PJ ;
Koenderman, L .
CELLULAR SIGNALLING, 1998, 10 (09) :619-628
[10]   Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor [J].
Dijkers, PF ;
van Dijk, TB ;
de Groot, RP ;
Raaijmakers, JAM ;
Lammers, JWJ ;
Koenderman, L ;
Coffer, PJ .
ONCOGENE, 1999, 18 (22) :3334-3342